1122448

Amryt Pharmaceuticals, Inc. — FEI 3009569098

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 23, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)